Contact

Improvement of Bioavailability

API & Drug Product Development >> Preformulation & Material Science >> Solubility Assessment & Enhancement

Glatt can optimize the active substance release and bioavailability by specific optimized formulation and process methods depending on the physico-chemical property of the active substance.

Contact

Micropx™- Micro Pelletizing Technology

API & Drug Product Development >> Preformulation & Material Science >> Solubility Assessment & Enhancement

The Glatt MicroPX™ technology (micro pelletizing technology) is a continuous fluidized bed agglomeration procedure for the manufacture of pellets and micropellets with a very high active ingredient content.

Contact

Taste Masking By Micro-Pelletizing of APIs

API & Drug Product Development >> Preformulation & Material Science >> Taste Masking

Glatt has many years of experience and expertise in the taste masking of APIs. With our technologies and formulation approaches, we are able to achieve effective taste masking of drugs. A proven approach is the micro-pelletizing of APIs with the subsequen

Contact

Powder Physical Characterization

API & Drug Product Development >> Preformulation & Material Science >> Particle Size Reduction & Micronization

The formulation development center at Ascent offers physical characterization of powders which includes particle size distribution, bulk and tap density determination, flow properties etc.

Contact

Characterizing & Modifying Drug Substances Properties

API & Drug Product Development >> Preformulation & Material Science >> Overview

With expertise in characterizing and modifying a drug substance’s physical, chemical and mechanical properties, our objective is to help you assess and choose the best solid form for progression into animal and human dosing trials.

Contact

Biopolymers

API & Drug Product Development >> Preformulation & Material Science >> Overview

Innovative, non-toxic and fully biodegradable biopolymers, made of hydrophilic (PEG or modified PEG) and lipophilic (PLA, PLGA, CPL) blocks.

Contact

Drugs Excipient Compatibility Study

API & Drug Product Development >> Preformulation & Material Science >> Excipient Screening

Ascents offerings includes binary or ternary mixtures of API with excipients from various functional categories such as diluents, binders, glidants, disintegrants, lubricants etc., packaging material compatibility studies, selection of excipients for form

Contact

Process Analytical Technology and Pharmaceutical Quality by Design

API & Drug Product Development >> Preformulation & Material Science >> Overview

AMRI's PAT approach is consistent with the FDA perspective that quality cannot be tested into products, but should be built in.

Contact

Polymers for Vectorization

API & Drug Product Development >> Preformulation & Material Science >> Overview

Alternative to the use of inactivated viruses. Synthetic cationic polymers for nucleic acids (DNA or RNA) and hydrophobic APIs transfer.

Contact

PharmaCompass >>